Latest news

Search
Categories
News archive

CEO Comment First Quarter 2021

23 April, 2021

IMPORTANT MILESTONES ACHIEVED IN BOTH BUSINESS AREAS Successful upscaling of the production of silica to ton scale advances Nanologica’s position in the preparative chromatography field. At the same time, the company’s platform for inhalation advances through a toxicology program, with eyes set on clinical studies. Sales for the first quarter amounted to TSEK 5,622, where the majority is derived from our partner project with Vicore Pharma. This is our strongest first quarter yet and we

Read more »

Nanologica Interim Report Jan-Mar 2021

23 April, 2021

SUMMARY OF THE PERIOD FINANCIAL OVERVIEW Net revenue increased by 54 percent to TSEK 5,622 (3,654) The operating profit and loss for the period was TSEK -6,768 (-6,032) Profit and loss after tax for the period was TSEK -7,845 (-6,705) Earnings per share for the period was SEK -0.28 (-0.40) Cash and cash equivalents at the end of the period amounted to TSEK 57,069 (1,273)   SIGNIFICANT EVENTS DURING THE FIRST QUARTER Test material from

Read more »

Nanologicas delårsrapport jan-mar 2021

23 April, 2021

PERIODEN I KORTHET FINANSIELL SAMMANFATTNING ·         Nettoomsättningen ökade med 54 procent till 5 622 TSEK (3 654) Rörelseresultatet uppgick till -6 768 TSEK (-6 032) Resultatet efter skatt uppgick till -7 845 TSEK (-6 705) Resultat per aktie var -0,28 SEK (-0.40) Likvida medel uppgick på balansdagen till 57 069 TSEK (1 273)   VÄSENTLIGA HÄNDELSER UNDER PERIODEN ·         Testmaterial från uppskalning till volymproduktion av silika godkänns ·         Vetenskapliga rådgivare inom inhalation anlitas ·         Ramavtal med läkemedelsbolaget

Read more »

Nanologica Announces Date Change for Annual Report

21 April, 2021

Nanologica AB (publ) has changed the previously disclosed publication date of April 23, 2021 for the company’s annual report 2020 to May 5, 2021.    Financial calendar 2021 Interim report January-March 2021                         April 23, 2021 Annual Report 2020                                                        May 5, 2021 Interim report January-June 2021       

Read more »

Nanologica ändrar datum för publicering av årsredovisning 2020

21 April, 2021

Nanologica AB (publ) har ändrat datum för publicering av bolagets årsredovisning 2020 från den 23 april till den 5 maj.    Finansiell kalender 2021 Delårsrapport januari-mars 2021                             23 april, 2021 Årsredovisning 2020                                                       5 maj, 2021 Delårsrapport januari-juni 2021                       

Read more »